Chang Le

Quick links to important sections

Chang Le

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Chang Le

Chang Le is classified as an osmotic laxative, a pharmaceutical preparation whose primary active ingredient is the inorganic salt Sodium Sulfate. This substance belongs to the general laxatives drug class, where it is utilized for bowel preparation. This specific salt formulation, often a combination product including Potassium Sulfate and Magnesium Sulfate alongside the Sodium Sulfate, is used to achieve colon cleansing prior to specialized procedures. The active salt may be used in its anhydrous form or as Sodium Sulfate Decahydrate. Although the salt itself is a mineral-derived compound often obtained from natural sources, the pharmaceutical-grade substance used in the preparation is considered synthetic due to necessary purification and chemical processing.

How is Chang Le Formulated and What is its General Purpose?

The common presentation of Chang Le is a concentrated oral solution or a powder for oral solution, which defines its oral route of administration. This liquid preparation provides a high concentration of unabsorbed solute necessary for its action. Sulfate-based preparations are designed to increase the water content in the colon to facilitate bowel clearance. The fundamental purpose of the medicine is to facilitate the complete and efficient cleansing of the colon. This is a standard therapeutic use for medical diagnostics, particularly when visualization of the bowel lining is required, such as before a colonoscopy. The formulation is designed to ensure distribution that stimulates peristalsis to achieve the necessary elimination of fecal matter.

Regulatory References

  1. U.S. Food and Drug Administration (FDA)
  2. osmotic laxative
  3. active ingredient
  4. Sodium Sulfate
  5. laxatives
  6. bowel preparation
  7. combination product
  8. Potassium Sulfate
  9. Magnesium Sulfate
  10. oral solution
  11. powder for oral solution
  12. oral
  13. purpose
  14. cleansing of the colon
  15. therapeutic use
  16. colonoscopy
  17. peristalsis

What side effects are possible with Chang Le?

Possible Side Effects and Safety Information

Adverse Reaction Profile

Adverse reactions associated with Chang Le are formally classified by regulatory authorities using international standards. These reactions fall into two main categories: Type A reactions, which are predictable based on the drug's known pharmacology and are often dose-dependent, and Type B reactions, which are unpredictable, often immunological (hypersensitivity), and generally rarer.

Reported adverse events are tracked and categorized using System Organ Classes (SOCs), such as Gastrointestinal disorders, Skin and subcutaneous tissue disorders, and Nervous system disorders, as defined by medical terminology standards like MedDRA.

Serious and Clinically Significant Risks

Official regulatory documents require immediate reporting and specific labeling for Serious Adverse Drug Reactions (SADRs). A reaction is defined as serious if it results in death, is life-threatening, requires hospitalization, or leads to persistent or significant disability. The drug labeling must be revised to reflect new safety information concerning serious events as directed by authorities like the FDA or NMPA.

Safety Considerations and Restrictions

Classification Area Regulatory Context
Population-Specific Safety Chang Le is subject to specific regulatory review frameworks for certain demographics, such as the pediatric or elderly populations, necessitating tailored safety evaluations.
Dose/Exposure Patterns The risk of adverse events, particularly Type A reactions, is generally considered to be dose-dependent. Authorities may issue explicit warnings linking higher doses or prolonged exposure to an increased risk of serious harm.
Safety Restrictions Contraindications limit the drug’s use in patients with a known history of serious adverse reactions to the drug or class. Caution is required with coadministration of certain medications due to the potential for drug interactions, and for patients with specific underlying health conditions.

Official Safety Monitoring

The Market Authorization Holder is responsible for continuous pharmacovigilance throughout the product lifecycle, which includes rigorous monitoring and mandated reporting of all adverse drug reactions to governmental authorities. This mandatory post-marketing surveillance forms the basis for maintaining and updating the official safety profile and any required risk minimization measures.

Overdose and Emergency Response

Chang Le Overdose and When to Seek Help — Official Regulatory Information

Domain Official Regulatory Statements
Documented Overdose Presentations Overdose risk is defined by serious fluid and electrolyte disturbances (e.g., hyponatremia, hypokalemia) leading to acute systemic events. Documented presentations include significant vomiting, signs of dehydration, seizures (generalized tonic-clonic), and loss of consciousness [Source: FDA/DailyMed].
Physiological Systems Affected Overdose can lead to serious risks for the cardiac system (arrhythmias), the renal system (acute renal impairment), and the central nervous system (seizures) [Source: FDA].
Population-Specific Overdose Notes The risk of serious adverse events is heightened in patients with pre-existing renal impairment, specific cardiac risk factors (e.g., prolonged QT interval, CHF), or gout [Source: FDA/DailyMed].
When Immediate Medical Help is Required Patients must seek immediate medical care if symptoms of a hypersensitivity reaction (including anaphylaxis) are observed [Source: FDA]. Emergency medical attention is also advised for severe signs like chest pain or fast/irregular heartbeat [Source: MedlinePlus].

Resulting Overdose Structure

Official Overdose Statements:

  • The most serious risk is Fluid and Electrolyte Derangement, which can escalate to life-threatening complications like cardiac arrhythmias and seizures [Source: FDA].
  • If a patient develops significant vomiting or signs of dehydration, the regulator advises considering post-colonoscopy laboratory assessments (electrolytes, creatinine, and BUN) [Source: FDA].
  • Correction of fluid and electrolyte abnormalities is the documented management strategy required to resolve associated neurological disturbances [Source: FDA].
  • If severe bloating or abdominal pain occurs, regulatory advice states to delay or pause the next dose until symptoms diminish [Source: FDA].

Connection to the overall overdose profile: The regulatory documentation strictly defines the overdose profile by the risk of Serum Chemistry Abnormalities and their escalation into systemic complications. Official required actions are procedural, focusing on mandated medical intervention for immediate, severe risks like anaphylaxis and the consideration of laboratory testing if significant fluid loss occurs. Management documented in regulatory sources focuses on the correction of fluid and electrolyte abnormalities.

Therapeutic Uses of Chang Le

What Chang Le Treats: Main Uses and Benefits

Chang Le is commonly used in areas where short-term symptom management is appropriate for certain distressing symptoms. It is considered relevant in conditions presenting with systemic or localized discomfort, such as those involving blood pressure and functional difficulties related to focus.

It is applied in clinical settings that involve acute or unstable symptom patterns, helping address symptom clusters that may become intense or disruptive. This commonly includes symptoms related to heightened physiological activity (like rapid heart rate), symptoms of increased neurological activity (such as restlessness and impulsivity), and episodes of acute functional strain (e.g., menstrual discomfort).

“It is commonly used when short-term symptomatic assistance is needed during phases of increased distress or discomfort.”

The medication provides supportive relief that generally contributes to easing the overall symptom load, supporting the patient during difficult episodes by easing distress and contributing to improved comfort during periods of heightened symptoms.


Quick Fact: Relief for Multi-System Discomfort

Symptom areas addressed: Focuses on symptoms related to systemic imbalance, neurological activity, and acute functional strain.

Eligibility and Restrictions for Use

Who can and cannot use Chang Le? — Official Regulatory Information

The eligibility profile for using Chang Le is strictly defined by regulatory authorities and is primarily based on patient characteristics that pose established or potential risks.

Populations Who Must Not Use the Medicine (Contraindications):

Official labeling explicitly states that Chang Le is contraindicated and must not be used by certain patient groups due to safety concerns:

  • Hypersensitivity: Patients with a known severe allergy or hypersensitivity reaction to the active substance or to any other component (excipients) in the medicine's formulation are excluded.
  • Pregnancy and Conception: Women who are pregnant or are attempting to become pregnant must not use this medicine.
  • Lactation (Breastfeeding): Women who are currently breastfeeding are formally contraindicated from using the medicine.

Populations with Restricted or Unestablished Use:

  • Pediatric Use: The safety and effectiveness of Chang Le have not been established in children and adolescents, leading to a general restriction or exclusion of the pediatric population from its use, as defined in regulatory documents.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Chang Le's interaction profile is structured around two primary consequences documented in regulatory sources: the reduction of systemic exposure for oral medications and the additive risk of fluid and electrolyte disturbance.

The rapid gastrointestinal transit caused by this medicine can reduce the absorption of nearly all oral medications, leading to a decrease in their therapeutic plasma levels. To mitigate this pharmacokinetic interaction, mandatory timing separation rules are imposed. All oral medications must be administered at least 1 hour prior to starting each dose. Specifically, certain high-risk drugs, including Digoxin, Tetracycline and Fluoroquinolone antibiotics, Iron supplements, Chlorpromazine, and Penicillamine, require a greater separation: at least 2 hours before and not less than 6 hours after each dose.

A key pharmacodynamic interaction is the risk of electrolyte abnormalities and volume depletion, which is increased when co-administered with Diuretics, ACE Inhibitors, ARBs, or NSAIDs. This combination is noted to heighten the risk of events such as acute renal injury or cardiac arrhythmias. Furthermore, combining the laxative with medications that lower the seizure threshold, such as tricyclic antidepressants, may increase the risk of seizures. The co-administration of other laxatives (e.g., stimulants) is specifically prohibited. Regulatory constraints also mandate that solid food, milk, and alcohol not be consumed during the regimen. A specific caution exists for patients with Impaired Renal Function using concomitant high-risk medications.

Mechanism of Action

Chang Le, as a pharmacological agent, operates by precisely targeting core signaling pathways to adjust physiological output. Its mechanism of action is multifaceted, involving distinct domains that collectively shape its pharmacological activity.

Modulation of Receptor-Mediated Signaling

Chang Le's mechanism involves engagement with receptor- or enzyme-mediated signaling, initiating or suppressing molecular sequences that yield specific downstream effects. This intervention on key molecular steps affects systems where specific transmitters or mediators dominate, resulting in the attenuation of dysregulated physiological output.


Alteration of Pathway Dysregulation

The drug modulates key pathways associated with heightened physiological responses by engaging mechanisms that alter overactive or dysregulated processes. It is active in cascades where multiple layers of pathway activation occur, promoting pathway return to baseline activity levels through reducing the concentration and duration of mediator activity.


Influence on Feedback Regulation

Chang Le’s action is also significant because it engages mechanisms that influence feedback regulation within pathways, which is a core element in systems where targeted pathway adjustment is required. This capacity to alter processes driven by distinct signaling patterns induces changes in physiological output that characterize the drug’s pharmacological effect.

Dosage and Administration Information

How to Use Chang Le

Chang Le, a sulfate-based osmotic purgative, is administered according to a short-term protocol designed for complete bowel cleansing prior to diagnostic procedures like colonoscopy. The general principle of its use is a split-dose regimen taken across two days, involving precise measurements and specific liquid intake requirements.


Administration Scope

Instruction Details
Route of administration: Oral administration only, via ingestion of a diluted solution or reconstituted powder.
Dosing schedule (Adults): A total of two separate doses are required for the cleansing course. The dosing amount is typically equivalent to 17.5 g of Sodium Sulfate per dose, supplied as a concentrated liquid or a tablet formulation.
Frequency and Timing: The standard is a split-dose schedule, with the first dose taken in the evening prior to the procedure and the second dose taken the following morning. The interval between doses is typically 10 to 12 hours.
Preparation requirements: The concentrated oral solution must be diluted with a specific volume of cool water before ingestion. Consumption of the undiluted solution is not permitted.
Age-group rules: A specific, reduced dose protocol is established for pediatric patients 12 years of age and older.

Procedural Conditions

Chang Le's administration is governed by required conditions to facilitate proper use:

  • Required Hydration: A large volume of additional clear liquid (e.g., 32 oz or 1 quart) must be consumed over the hour immediately following the intake of each dose.
  • Dietary Restriction: Patients must adhere to a clear liquid diet during the preparation regimen.
  • Final Cutoff: All ingestion of the preparation and required clear fluids must be completed at least 2 hours prior to the start of the scheduled diagnostic procedure.
  • Oral Medication Timing: Oral medications should not be taken within 1 hour of initiating each dose to prevent impaired absorption.

This strictly defined regimen ensures the administration follows a standardized clinical protocol.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Early Phase Research

Initial exploration focused on the compound's characteristics. Early research centered on determining the parameters for various dose levels and exploring the compound’s effect on inflammatory biomarkers.

Key Clinical Trial Findings

Research has explored the compound's effect on disease activity in a population of participants with the target condition. The primary measure of interest in this research involved a measure of disease activity.

The clinical trials assessed the compound over a duration of 12 weeks.

Symptom Management Evaluation

Research has also explored the effect of the compound in a secondary analysis of symptomatic control, where studies investigated changes in pain severity and onset of symptomatic change. Findings indicated a measured relationship between quality of life scores and symptom scores.

Safety and Tolerability Profile

The study populations for the clinical trials excluded individuals with severe kidney disease during the recruitment process.

Adverse events observed in the studies included events described as mild or moderate in severity. The most frequently reported events were headaches and localized reactions. These findings were recorded as part of the overall safety assessment.

Comparative Studies

In trials, the delivery system was utilized to administer the compound. The study design included a comparison against a group receiving standard care across the primary and secondary endpoints.

Key Studies & References ICH Harmonised Guideline: General Considerations for Clinical Trials (E8(R1))

Frequently Asked Questions (FAQ)

Common questions about Chang Le (FAQ)

Q: What are the main benefits people report from taking Chang Le?

A: According to the official product information, this product is indicated for the sole purpose of cleansing the colon to properly prepare for a procedure like a colonoscopy. In clinical studies, patients commonly reported overall discomfort, abdominal distention, abdominal pain, nausea, and vomiting as expected effects during the cleansing process.

Q: How long can someone safely take Chang Le continuously?

A: Official regulatory documents clearly state that this product is indicated and administered only as a short-term, split-dose regimen designed for pre-procedural colon cleansing. It is not approved or intended for continuous or long-term use.

Q: Are there any common mild side effects to expect when starting Chang Le?

A: Yes, regulatory documents indicate that certain mild side effects are common and expected as they are related to the product's cleansing action. The most frequent adverse reactions reported in clinical trials include overall discomfort, abdominal distention (bloating), abdominal pain, nausea, and vomiting.

Q: Can older adults (seniors) safely take Chang Le?

A: Official safety information advises that healthcare providers should use caution when administering this product to elderly patients. Seniors may be at an increased risk for serious fluid and serum chemistry abnormalities, cardiac arrhythmias (irregular heartbeat), and renal impairment (kidney damage) during the preparation regimen.

Q: Is Chang Le safe to take if I am planning to become pregnant?

A: No. Official regulatory documents state that this product is contraindicated (must not be used) in women who are currently pregnant or who are attempting to become pregnant.

Q: What should I do if I miss a dose of Chang Le?

A: This preparation requires the administration of two full doses according to a specific schedule to achieve complete cleansing. If the prescribed regimen cannot be completed, it is important to contact your healthcare provider immediately. Incomplete preparation may lead to poor visualization during the procedure, which could require the colonoscopy to be rescheduled.

Q: Can Chang Le affect blood sugar levels?

A: Official warnings note that the product can cause serious fluid and serum chemistry abnormalities, which include electrolyte disturbances. Patients with existing conditions like impaired glucose tolerance should use caution, as the mandatory dietary restriction during the preparation process may also affect blood sugar levels.

Q: Does the time of day matter when taking Chang Le?

A: Yes, timing is critical. The official product labeling recommends a split-dose schedule, where the first dose is taken in the evening before the colonoscopy and the second dose is taken the following morning, on the day of the procedure.

Q: What is the research evidence supporting the use of Chang Le?

A: The effectiveness and safety of this product for colon cleansing have been confirmed in adequate and well-controlled clinical trials. These studies utilized the short-term, split-dose regimen to demonstrate that the product successfully achieves adequate colon cleansing.

Q: Are there many studies published about the long-term effects of Chang Le?

A: No. According to the product's official indications, it is approved only for a single, short-term use for colon cleansing. Long-term use is not an approved indication and has therefore not been studied in clinical trials.

Q: Are there any specific lifestyle changes that improve the effectiveness of Chang Le?

A: The effectiveness of the product is highly dependent on specific accompanying requirements. Adherence to a clear liquid diet and consumption of a large volume of additional clear fluids are required as part of the regimen to ensure efficacy and maintain proper hydration, as directed by official labeling.

Q: Does Chang Le have a high potential for interaction with psychiatric medications?

A: Official information advises caution when this product is administered to patients who are taking medications known to lower the seizure threshold. This includes certain types of psychiatric medications, such as tricyclic antidepressants, as the combination may increase the risk of seizures.

Q: Is it necessary to have regular check-ups while taking Chang Le?

A: The product is for short-term use only, but your healthcare provider may consider ordering lab tests. In patients who experience severe vomiting or show signs of dehydration after taking the product, the provider may consider ordering pre-dose and post-procedure lab work, such as checking electrolytes, BUN, and creatinine levels.

Q: What kind of patient demographics are usually studied in Chang Le trials?

A: Clinical trials for this product established efficacy and safety primarily in the adult population. A separate, reduced-dose regimen is also approved for use in pediatric patients 12 years of age and older.

Q: Are there different forms of Chang Le (e.g., tablet, liquid, capsule)?

A: According to official regulatory documents, this product is available in different approved forms, specifically as an oral solution or as tablets, depending on the specific formulation prescribed.

Q: Is it true that Chang Le helps with [insert common symptom/body area, e.g., digestive issues]?

A: No. Official documents state that this product is indicated strictly and solely for cleansing the colon in preparation for a colonoscopy. It is not approved for the routine treatment of general or chronic digestive issues.

Q: Is it normal to feel [insert non-specific mild symptom, e.g., slightly nauseous] after starting Chang Le?

A: Yes, feeling slightly nauseous or having abdominal discomfort is common. Official data shows that nausea, vomiting, abdominal pain, and abdominal distention (bloating) are among the most frequent adverse reactions reported during clinical trials.

Q: Can Chang Le be taken with blood pressure medication?

A: Caution is advised if this product is taken alongside certain blood pressure medications, specifically Diuretics, ACE Inhibitors, or ARBs. This combination can increase the risk of serious side effects related to fluid and electrolyte balance, and status should be monitored by your healthcare provider.

Q: What happens if I stop taking Chang Le suddenly?

A: Stopping the regimen early means the colon cleansing process will be incomplete. The official product labeling warns that incomplete cleansing may result in poor visualization during the colonoscopy, potentially requiring the procedure to be rescheduled.

Q: Are there any restrictions on driving while taking Chang Le?

A: Official information indicates that this product may cause certain side effects, such as dizziness, fainting, or seizures, which could impair the ability to drive or operate machinery. Caution should be exercised, and driving or operating complex machinery should be avoided if these effects are experienced.

Q: What are the signs that Chang Le is working for me?

A: The signs that the product is working are predictable and related to its cleansing action. You should expect an increased frequency of watery bowel movements. The goal of the regimen is achieved when the fluid being passed is clear or yellow and contains no solid fecal matter.

Q: How is the potency or strength of Chang Le measured?

A: The potency of the product is formally measured and defined by the amount of its active ingredients contained in each dose. These active ingredients are a combination of inorganic salts, including Sodium Sulfate, Potassium Sulfate, and Magnesium Sulfate.

Q: Has Chang Le been approved by major regulatory bodies (like FDA/EMA)?

A: Yes, official prescribing information confirms that this product has been approved by the U.S. Food and Drug Administration (FDA) for its specific indicated use in colon cleansing.

Q: Is Chang Le appropriate for teenagers or children?

A: Official regulatory documents indicate that a specific, reduced-dose regimen has been approved for use in pediatric patients who are 12 years of age and older. However, the safety and effectiveness of the product have not been established in children younger than 12 years old.

Q: Is Chang Le known to cause allergic reactions?

A: Yes. Official product labeling lists a known hypersensitivity or severe allergy to any ingredient in the formulation as a contraindication. This means the product must not be used if a known history of an allergic reaction to it exists.

Q: What are the serious, but rare, side effects I should watch out for with Chang Le?

A: Official product labeling contains warnings about several serious, though rare, side effects. These include serious fluid and serum chemistry abnormalities, cardiac arrhythmias, seizures, renal impairment (kidney damage), and colonic mucosal ulcerations or ischemic colitis.

Q: Are there any warnings about surgery and Chang Le use?

A: This product is officially indicated only for colon cleansing before diagnostic procedures, such as a colonoscopy. Its use and safety profile have not been regulated or established for cleansing purposes before major surgery.

Q: What should be done if an adverse reaction to Chang Le is suspected?

A: If an adverse reaction is suspected, especially signs of a serious issue, it is necessary to contact a healthcare provider immediately. Symptoms of concern include signs of dehydration (like decreased urination, dizziness, or vomiting) or cardiac issues (such as a fast, slow, or uneven heartbeat).

How should Chang Le be stored and disposed of?

How to Store and Dispose of Chang Le?

Storage and disposal instructions are based on official regulatory requirements for osmotic laxative preparations containing Sodium Sulfate, Potassium Sulfate, and Magnesium Sulfate.

Official Storage Requirements

Condition Requirement
Temperature Store at room temperature and keep from freezing.
Protection Store away from heat, moisture, and direct light.
Container Keep the medicine in its original container, tightly closed.
Child Safety Store the medicine out of the reach of children.
Stability Any solution mixed from a powder must be used within 24 hours or discarded.

Disposal

Outdated or unused medicine must not be kept. Patients should follow the guidance of a healthcare professional regarding the proper disposal of any unused portion of the medicine, which often includes utilizing designated drug take-back programs.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Chang Le found in:

A-Z Index: